Drugs · acquisition-cost intelligence
Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide
Brompheniramine maleate, pseudoephedrine hydrochloride,· ingredient brompheniramineSubstituted alkylamines· BROMPHENIRAMINE MALEATE 2 mg/5mL; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/5mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.07201
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 7 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other brompheniramine products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| CAREONE CHILDRENS COLD COUGH | $0.01833 | −$0.05370 |
| Childrens Dibromm Cold and Allergy | $0.02418 | −$0.04780 |
| Childrens Cold and Allergy | $0.03501 | −$0.03700 |
| CareOne Childrens Cold and Cough | $0.06301 | −$0.00900 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.